Progress in ensuring adequate access to internationally controlled substances for medical and scientific purposes

Preface  
Contents
Executive Summary

Chapter I
Factors limiting the availability of narcotic drugs and psychotropic substances

Chapter II

Narcotic Drugs (full chapter)

 

Unbalanced increase in availability for consumption
Increase in availability of synthetic opioids and stable trend in the availability of morphine
Limited use of morphine for palliative care

                                                                                                                 Français Español عربي Русский 中文

Chapter III

Psychotropic substances (full chapter)

 

Global burden of disease and mental health disorders
Anxiety disorders
Diazepam: reported consumption
Epilepsy
Reported consumption of essential antiepileptics under international control
Importance of quality data on the consumption of psychotropic substances

Chapter IV

Implementation of recommendations made by the Board and of the recommendations contained in the outcome document of the special session of the General Assembly on the world drug problem held in 2016
A. Member States
B. Civil society organizations
C. International community

Chapter V
Conclusions and the way ahead

©1995-2019 International Narcotics Control Board